4.5 Article

Assessing adherence to objective disease monitoring and outcomes with adalimumab in a real-world IBD cohort

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Association of Biomarker Cutoffs and Endoscopic Outcomes in Crohn's Disease: A Post Hoc Analysis From the CALM Study

Walter Reinisch et al.

INFLAMMATORY BOWEL DISEASES (2020)

Article Gastroenterology & Hepatology

Deep Remission at 1 Year Prevents Progression of Early Crohn's Disease

Ryan C. Ungaro et al.

GASTROENTEROLOGY (2020)

Article Gastroenterology & Hepatology

Association of Biomarker Cutoffs and Endoscopic Outcomes in Crohn's Disease: A Post Hoc Analysis From the CALM Study

Walter Reinisch et al.

INFLAMMATORY BOWEL DISEASES (2020)

Article Medicine, General & Internal

The usefulness of fecal calprotectin in assessing inflammatory bowel disease activity

Yang Woon Lee et al.

KOREAN JOURNAL OF INTERNAL MEDICINE (2019)

Review Gastroenterology & Hepatology

Inflammatory bowel disease therapy: blockade of cytokines and cytokine signaling pathways

Jesus K. Yamamoto-Furusho

CURRENT OPINION IN GASTROENTEROLOGY (2018)

Article Gastroenterology & Hepatology

Management Strategies to Improve Outcomes of Patients With Inflammatory Bowel Diseases

Jean-Frederic Colombel et al.

GASTROENTEROLOGY (2017)

Review Medicine, General & Internal

Crohn's disease

Joana Torres et al.

LANCET (2017)

Review Medicine, General & Internal

Ulcerative colitis

Ryan Ungaro et al.

LANCET (2017)

Article Gastroenterology & Hepatology

Compliance with the faecal calprotectin test in patients with inflammatory bowel disease

Chloe Marechal et al.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2017)

Review Gastroenterology & Hepatology

Systematic review with meta-analysis: mucosal healing is associated with improved long-term outcomes in Crohn's disease

S. C. Shah et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)

Review Gastroenterology & Hepatology

Mucosal Healing Is Associated With Improved Long-term Outcomes of Patients With Ulcerative Colitis: A Systematic Review and Meta-analysis

Shailja C. Shah et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)

Article Gastroenterology & Hepatology

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target

L. Peyrin-Biroulet et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)

Article Gastroenterology & Hepatology

Adalimumab Induces Deep Remission in Patients With Crohn's Disease

Jean-Frederic Colombel et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)

Article Gastroenterology & Hepatology

Endoscopic Assessment and Treating to Target Increase the Likelihood of Mucosal Healing in Patients With Crohn's Disease

Guillaume Bouguen et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)

Review Gastroenterology & Hepatology

Treating beyond symptoms with a view to improving patient outcomes in inflammatory bowel diseases

William J. Sandborn et al.

JOURNAL OF CROHNS & COLITIS (2014)

Review Gastroenterology & Hepatology

Review of the disease course among adult ulcerative colitis population-based longitudinal cohorts

Fernando Magro et al.

INFLAMMATORY BOWEL DISEASES (2012)

Article Gastroenterology & Hepatology

Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis

Jean Frederic Colombel et al.

GASTROENTEROLOGY (2011)

Review Gastroenterology & Hepatology

Long-term Complications, Extraintestinal Manifestations, and Mortality in Adult Crohn's Disease in Population-Based Cohorts

Laurent Peyrin-Biroulet et al.

INFLAMMATORY BOWEL DISEASES (2011)

Article Gastroenterology & Hepatology

Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease

Filip Baert et al.

GASTROENTEROLOGY (2010)

Article Gastroenterology & Hepatology

Mucosal healing in inflammatory bowel disease: Results from a Norwegian population-based cohort

Kathrine Frey Froslie et al.

GASTROENTEROLOGY (2007)